Evolution of a novel series of [(N,N-dimethylamino)propyl]- and piperazinylbenzanilides as the first selective 5-HT1D antagonists

  • J Med Chem. 1994 Jul 22;37(15):2253-7. doi: 10.1021/jm00041a001.
J W Clitherow  1 ,  D I Scopes ,  M Skingle ,  C C Jordan ,  W Feniuk ,  I B Campbell ,  M C Carter ,  E W Collington ,  H E Connor ,  G A Higgins, et al.
Affiliations
  • 1. Department of Medicinal Chemistry, Glaxo Research and Development Ltd., Ware, Hertfordshire, England.
PMID: 8057272 DOI: 10.1021/jm00041a001
Products